Can-Fite BioPharma Ltd.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-12.1M | $-12.1M | $26.0K | $355.0K |
| FY2021 | $-9.9M | $-9.9M | $11.0K | $466.0K |
| FY2022 | $-10.8M | $-10.8M | $9.0K | $263.0K |
| FY2023 | $-8.4M | $-8.4M | $2.0K | $261.0K |
| FY2024 | $-7.6M | $-7.6M | $5.0K | $362.0K |